Study Stopped
departmental financial support withdrawn
Incidence of Respiratory Depression in Cesarean Section
A Prospective, Observational, Double-blind (Black-Box) Study Evaluating Incidence, Severity and Predictive Factors of Respiratory Depression During Postoperative Neuraxial Opioid Analgesia in Obstetric Patients After Cesarean Delivery Using Current Standard Intermittent Postoperative Monitoring Compared to Continuous Pulse Oximetry / Capnography
1 other identifier
observational
100
1 country
1
Brief Summary
This study is designed to determine the incidence and severity of respiratory depression in elective cesarean section patients who have received a spinal or epidural narcotic called duramorph for management of postoperative pain. A monitoring device called a capnograph as well as a device called a pulse oximeter is placed on the patient once in the recovery room after delivery. The capnograph monitors the carbon dioxide level that the patient breathes out as well as their respiratory rate. The pulse oximeter is a device that is taped on the patient's finger and measures their oxygen saturation level. The monitoring is maintained for 18-24 hours after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 12, 2010
CompletedFirst Posted
Study publicly available on registry
August 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedNovember 8, 2017
February 1, 2017
3.9 years
August 12, 2010
November 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RESPIRATORY DEPRESSION
RESPIRATORY DEPRESSION OBSERVATION ONLY OF CURRENT PRACTICES, DOES NOT INVOLVE TREATMENT
24 HOURS
Study Arms (1)
Cesearean sections receiving duramorph
Eligibility Criteria
subjects having an elective cesearean section and having as their anesthetic either a spinal or epidural and receiving duramorph
You may qualify if:
- Are female \>= 18 years of age and \<=55 years of age with ASA class I-III
- Schedule for cesarean surgery
- Are willing and able to sign informed consent form for this study
- Are willing and able to follow the instruction in this study protocol
You may not qualify if:
- Have known contraindication/allergy to neuraxial anesthesia or morphine.
- Have an ASA class \> III
- Age \> 55 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wake Forest Universitylead
- Forsyth Medical Centercollaborator
Study Sites (1)
Forsyth Medical Center-Dept of OB Anesthesia
Winston-Salem, North Carolina, 27103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Pan, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2010
First Posted
August 13, 2010
Study Start
July 1, 2010
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
November 8, 2017
Record last verified: 2017-02